Review Article
Advances in Research on the circRNA-miRNA-mRNA Network in Coronary Heart Disease Treated with Traditional Chinese Medicine
Table 3
The influence of active ingredients-miRNA in TCM on cardiovascular diseases.
| Active components | Cell types | MiRNAs | Targets | Effects (references) |
| Tanshinone IIA | Macrophages | miR-375 | KLF4 | Anti-AS [33] | NRCMs | miR-133 | MAPK ERK1/2 | Protecting cardiomyocytes [34] | H9c2 | miR-152-3p | PTEN | Inhibiting apoptosis [35] | Salvianolate | H9c2 | miR-122-5p | Bax, Bcl-2 | Inhibiting apoptosis [36] | Astragaloside IV | H9c2 | miR-23a/miR-92a. | PI3K/AKT | Protects rat cardiomyocytes [37] | Notoginsenoside R1 | H9c2 | miR-21 | PI3K/AKT | Cardioprotective actions [38] | Ginsenoside Rb1 | NRCMs | miR-208 | ā | Protecting H/I impaired NRCMs [39] | Ginkgolide B | EPC | miR-126 | Akt | Promoted cell growth [40] | Crataegus special extract | HUVEC | miR-155 | eNOS | Protecting vascular [41] |
|
|
EPC: endothelial progenitor cells; HUVEC: human umbilical vein endothelial cells; NRCMs: neonatal rat cardiomyocytes.
|